Renal news roundup from AKF

Margie Smith, previously anonymous, has revealed herself as the living donor who gave Katisha Vertrees a second chance at life. Smith, a mother of two, was deeply moved by Katisha's story and acted immediately after seeing a social media post. Her decision to go public stemm...

The first successful kidney transplant took place on Dec. 23, 1954, in Boston. The groundbreaking procedure involved identical twins Ronald and Richard Herrick, making the risk of organ rejection low due to their shared DNA. The operation, which lasted just over an hour, marked a...

Boehringer Ingelheim and Rectify Pharma have announced a partnership aimed at developing oral medicines for chronic kidney disease (CKD), with the deal valued at up to $448 million. The collaboration, which marks Rectify's first major pharmaceutical alliance, centers on leve...

A clinical decision support tool has been shown to significantly improve the reinitiation rates of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) for those with CKD, according to a study presented at the American Society of Nephrology Kidn...

A study published in the journal Neurology shows a possible link between poor kidney health and an acceleration of the onset of dementia and Alzheimer's disease. The article suggests that impaired kidney function may have wider implications for cognitive health than previous...

A low-protein diet remains a valuable strategy for managing CKD, potentially slowing progression and improving health outcomes, according to a review in the Journal of Internal Medicine. The review shows that excessive protein intake can lead to glomerular hyperfiltration and acc...

Semaglutide may reduce albuminuria and preserve glomerular filtration in patients with CKD and type 2 diabetes (T2D), according to research presented at a meeting of the American Society of Nephrology. The study found that semaglutide also reduced perirenal fat and inflammation, ...

The American Society of Nephrology's (ASN) artificial intelligence (AI) workgroup has introduced a clinical framework for responsible AI use in nephrology, focusing on patient benefits and continuous clinician involvement. Presented at ASN Kidney Week and published in the Jo...

CMS will end the End-Stage Renal Disease Treatment Choices model two years early after analyses showed it did not increase home dialysis or transplantation rates. The model, the largest experiment of its kind in United States health care, aimed to incentivize providers to transit...